CIK 0000822370
- Non-accelerated filer
- Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870419387
- Phone
- +1 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 11,205 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 34,380 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $3.44 ($34,378)
- 4 Open-market buy Director bought 4,552 shares at an average $3.81 ($17,337)
- 4 Open-market buy Director bought 15,000 shares at $3.65 ($54,735)
- 4 Grant or award Chief Executive Officer acquired 7,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award 10% owner acquired 12,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 12,000 shares (grant or award)
Page 13 of 25 · 488 filings